ACE and pityriasis rosea: According to Wilkin’s hypothesis [46–48], ACE inhibitors might raise plasma and tissue levels of kinins, which have pro-inflammatory effects linked to various cutaneous adverse reactions, including pityriasis rosea-like eruptions.